S Visonneau
Impact in
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Biochemistry top 5%
Papers in
- Immunology 19
- Immunotherapy and Immune Responses 10
- Immune Cell Function and Interaction 9
- Toxin Mechanisms and Immunotoxins 3
- Oncology 13
- CAR-T cell therapy research 11
- Co-authors
- D Santoli (28 shared papers)Alessandra Cesano (26 shared papers)David Kritchevsky (3 shared papers)Steven C. Clark (4 shared papers)S. A. Tepper (2 shared papers)Joseph A. Scimeca (2 shared papers)Michael H. Torosian (3 shared papers)K. Ann Jeglum (5 shared papers)
- Journals
- Cancer Immunology Immunotherapy (3 papers)Blood (3 papers)International Journal of Oncology (2 papers)The Journal of Immunology (2 papers)Oncology Reports (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
S Visonneau
34 papers receiving 933 citations
Peers
Comparison fields: 5 of 71
- Immunology 412
- Biochemistry 99
- Nutrition and Dietetics 193
- Oncology 341
- Hematology 126
Countries citing papers authored by S Visonneau
This map shows the geographic impact of S Visonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Visonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Visonneau more than expected).
Fields of papers citing papers by S Visonneau
This network shows the impact of papers produced by S Visonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Visonneau. The network helps show where S Visonneau may publish in the future.
Co-authors
The 25 scholars most cited alongside S Visonneau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. | 1998 | 136 |
| 2 | Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. | 1997 | 122 |
| 3 | 1993 | 80 | |
| 4 | 2004 | 74 | |
| 5 | Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice. | 1998 | 52 |
| 6 | Role of CD38 and its ligand in the regulation of MHC-nonrestricted cytotoxic T cells. | 1998 | 44 |
| 7 | 1990 | 39 | |
| 8 | 1993 | 39 | |
| 9 | 1998 | 38 | |
| 10 | 1993 | 35 | |
| 11 | Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer. | 2000 | 33 |
| 12 | 1994 | 30 | |
| 13 | Phase I clinical trial with a human major histocompatibility complex nonrestricted cytotoxic T-cell line (TALL-104) in dogs with advanced tumors. | 1996 | 26 |
| 14 | Adjuvant treatment of canine osteosarcoma with the human cytotoxic T-cell line TALL-104. | 1999 | 25 |
| 15 | Successful treatment of canine malignant histiocytosis with the human major histocompatibility complex nonrestricted cytotoxic T-cell line TALL-104. | 1997 | 23 |
| 16 | The human leukemic T-cell line, TALL-104, is cytotoxic to human malignant brain tumors and traffics through brain tissue: implications for local adoptive immunotherapy. | 2000 | 23 |
| 17 | Treatment of experimental glioblastoma with a human major histocompatibility complex nonrestricted cytotoxic T cell line. | 1995 | 22 |
| 18 | Cell therapy of a highly invasive human breast carcinoma implanted in immunodeficient (SCID) mice. | 1997 | 19 |
| 19 | 1996 | 19 | |
| 20 | 2000 | 17 |
About S Visonneau
S Visonneau is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Biotechnology, having authored 35 papers that have together received 999 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Virus-based gene therapy research (10 papers), Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (9 papers), RNA Interference and Gene Delivery (7 papers), Cancer Research and Treatments (5 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Fatty Acid Research and Health (3 papers). The work is most often cited by research in Immunology (412 citations), Biochemistry (99 citations), Nutrition and Dietetics (193 citations), Oncology (341 citations) and Hematology (126 citations). S Visonneau has collaborated with scholars based in United States, France and Italy. Frequent co-authors include D Santoli, Alessandra Cesano, David Kritchevsky, Steven C. Clark, S. A. Tepper, Joseph A. Scimeca, Michael H. Torosian, K. Ann Jeglum, Silvia Deaglio and Fabio Malavasi. Their work appears in journals such as Cancer Immunology Immunotherapy, Blood, International Journal of Oncology, The Journal of Immunology and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.